Dr. Ursula Matulonis is a world renowned clinician and researcher in ovarian cancer. She is the Chief of the Division of Gynecologic Oncology at the Susan F. Smith Center for Women’s Cancers at the Dana-Farber Cancer Institute. She is also a Professor of Medicine at Harvard Medical School. Her research focuses on targeted therapies for gynecologic malignancies, with a specific interest in the genetic changes in ovarian cancer and how they can lead to rational targeted drug selection.
Dr. Matulonis is the Principal Investigator on several clinical trials and translational studies for ovarian cancer. Dr. Matulonis is a Co-PI on an ovarian cancer SPORE project entitled "Identification of Oncogenic Mutations in Ovarian Cancer," and a Co-PI on the project "Genetic Relationships Between Breast and Ovarian Cancer" that is funded by the Breast Cancer Research Foundation. She is also a past recipient of a DF/HCC Ovarian Cancer SPORE Developmental Grant entitled "Genetic Fingerprinting of Ovarian Cancer."
She also serves on the National Comprehensive Cancer Network Ovarian Cancer Recommendation and Guideline Committee for both ovarian cancer and for the treatment of anemia and the Gynecologic Oncology Group Quality of Life Committee, and is a member of The Cancer Genome Atlas Project (TCGA) Endometrial Analysis Working Group. Dr. Matulonis is Medical Director and Board Member for the non-profit organization Ovations for the Cure. She is a recipient of the Dennis Thompson Compassionate Care Scholar award, the Lee Nadler "Extra Mile" Award, and was named one of Boston's Best Physicians in Medical Oncology by Boston Magazine numerous times. She serves on the editorial board of the Journal of Clinical Oncology.
